FuelCell Energy Inc. (NASDAQ:FCEL) caters to the Utilities space. It has a net profit margin of -17.10% and weekly performance is -21.08%. On the last day of trading company shares ended up at $8.05. FuelCell Energy Inc. (NASDAQ:FCEL) distance from 50-day simple moving average (SMA50) is 5.29%.
FuelCell Energy Inc. (NASDAQ:FCEL) announced that a 1-for-12 reverse stock split has become effective, and that trading of the Company’s common stock on a post-split basis will begin on Friday, December 4, 2015.
Yelp Inc. (NYSE:YELP) shares moved down -0.59% in last trading session and ended the day at $30.45. YELP Gross Margin is 91.40% and its has a return on assets of 3.10%. Yelp Inc. (NYSE:YELP) quarterly performance is 25.77%.
On 27 November, Yelp Inc. (NYSE:YELP) said that, it won the dismissal of a lawsuit by shareholders who claimed they were fraudulently misled about the authenticity and quality of its reviews, and whether Yelp manipulated those reviews to favor paying advertisers.
Diana Shipping Inc. (NYSE:DSX) caters to the Services space. It has a net profit margin of -32.70% and weekly performance is -16.14%. On the last day of trading company shares ended up at $4.00. Diana Shipping Inc. (NYSE:DSX) distance from 50-day simple moving average (SMA50) is -34.40%.
O 27 November, Diana Shipping Inc. (NYSE:DSX) said that, optionMONSTER’s Depth Charge monitoring system detected the purchase of 2,000 March 4 puts for $0.25. Volume surpassed open interest of 0 contracts, an indication new money was put to work.
Ecopetrol SA (NYSE:EC) shares moved down -6.26% in last trading session and ended the day at $7.49. EC Gross Margin is 30.90% and its has a return on assets of 2.50%. Ecopetrol SA (NYSE:EC) quarterly performance is -22.30%.
On 4 December, Ecopetrol SA (NYSE:EC) said that, it has received four bids for onshore exploration areas, missing company expectations as low oil prices and budget cuts curbed participation.
ProQR Therapeutics N.V. (NASDAQ:PRQR) caters to the Healthcare space. Its weekly performance is -11.51%. On the last day of trading company shares ended up at $8.38. ProQR Therapeutics N.V. (NASDAQ:PRQR) distance from 50-day simple moving average (SMA50) is -0.41%.
Zacks Investment Research upgraded shares of ProQR Therapeutics N.V. (NASDAQ:PRQR) from a hold rating to a buy rating in a research report released on Thursday morning, MarketBeat reports. Zacks Investment Research currently has $10.00 price target on the biopharmaceutical company’s stock.
Leave a Reply